Move to Main Content
Hot Keywords: compensation / Annual Report /
:::
Notices
Latest News

SFIPC now accepting applications for compensation in Pharmally International Holding Co., Ltd. (stock code: 6452, suspended trading on August 18, 2020)’s false financial report, misleading prospectus and stock price manipulation case.

 SFIPC now accepting applications for compensation in Pharmally International Holding Co., Ltd. (stock code: 6452, suspended trading on August 18, 2020)’s false financial report, misleading prospectus and stock price manipulation case.

※ Eligibility requirements:
1. False financial report case:
Goodwill stock buyers:
Those who purchased Pharmally International Holding Co., Ltd. shares from the stock market between August 9, 2017 and August 6, 2020 and who still suffered a loss after gains from selling Pharmally International Holding Co., Ltd. shares during the above period were deducted.
2. Misleading prospectus case:
Those who purchased Pharmally International Holding Co., Ltd. shares in 2017 from the primary market and still suffered a loss after gains from selling Pharmally International Holding Co., Ltd. shares between August 9, 2017 and August 6, 2020 were deducted.
3. Stock price manipulation case:
Those who purchased Pharmally International Holding Co., Ltd. shares from the stock market between August 29, 2018 and October 22, 2018 and who still suffered a loss after gains from selling Pharmally International Holding Co., Ltd. shares during the above period were deducted.

Those who are eligible should get all the documents ready and send them to SFIPC by June 6, 2022 (as shown on the postmark).

Please check SFIPC’s website (https://www.sfipc.org.tw) or call (02)2712-8899 for further information.

※ SFIPC website: https://www.sfipc.org.tw; service hotline: (02)2712-8899 address: 12F. , No.178, Sec. 3, Mincyuan E. Rd., Taipei City 105, Taiwan (R.O.C.)

Top
Update Date:2022/06/10 19:53